Mutasynthesis of Antibacterial Halogenated Actinomycin Analogues

Ziwei Yao,Changli Sun,Yuhui Xia,Fang Wang,Liwu Fu,Junying Ma,Qinglian Li,Jianhua Ju
DOI: https://doi.org/10.1021/acs.jnatprod.1c00294
IF: 5.1
2021-01-01
Journal of Natural Products
Abstract:Through precursor-directed biosynthesis, feeding halogenated (F-, Cl-, Br-, I-) or methoxy-substituted 4-methyl-3-hydroxyanthranilic acid (4-MHA) analogues to the acnGHLM-deleted mutant strain of Streptomyces costaricanus SCSIO ZS0073 led to the production of ten new actinomycin analogues (4-13). Several of the actinomycin congeners displayed impressive antimicrobial activities, with MIC values spanning 0.06-64 mu g/mL to clinically derived antibiotic resistant pathogens, including Staphylococcus aureus, Enterococcus faecium, and Candida albicans, with low cytotoxicity.
What problem does this paper attempt to address?